PARP1 and ovarian disorder: Therefore, the favorable effect of PARP-1 inhibition on endotoxin-induced ovarian disorders could be mediated by changes in the activation of proinflammatory transcription factors and intracellular signaling pathways as has been demonstrated in different models of inflammatory diseases[9,19,42].